The group studies the molecular alterations of endometrial and skin cancers, in correlation with clinical and pathological characteristics, using descriptive molecular pathology tools (immunohistochemistry, in situ hybridization, sequencing, epigenetics, gene gain and loss), as well as in vitro functional analysis in cell cultures (2D and 3D), and experimental animals. The objective is to transfer the results to clinical practice for the benefit of patients.
Kim, WH; Gomez-Izquierdo, L; Vilardell, F; Chu, KM; Soucy, G; dos Santos, LV; Monges, G; Viale, G; Brito, MJ; Osborne, S; Noe, J; Du, X
HER2 Status in Gastric and Gastroesophageal Junction Cancer: Results of the Large, Multinational HER-EAGLE Study
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY 26 239-245. .
Garrido, P; Aldaz, A; Vera, R; Calleja, MA; de Alava, E; Martin, M; Matias-Guiu, X; Palacios, J
Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH
CLINICAL & TRANSLATIONAL ONCOLOGY 20 443-447. .
Xavier Matias-Guiu Guia
Biomedicine I / Biomedicina I
2nd floor / 2a planta